Thymosin Alpha 1 Peptide Therapy
Understanding Thymosin Alpha-1
A neutral overview of thymosin alpha-1, a thymus-derived peptide studied in immunology research.
Important Information
Thymosin Alpha-1 is not FDA-approved and is not offered at Cienega Medical. This page is for general education only and is not medical advice.
What Is Thymosin Alpha-1?
Thymosin alpha-1 (Tα1), also called thymalfasin, is a 28-amino-acid peptide originally isolated from a thymus-gland extract and now produced synthetically. It has been the subject of laboratory and clinical research in the field of immunology. In the United States, thymosin alpha-1 is not an FDA-approved drug and is classified as a research peptide. A synthetic version is registered as a pharmaceutical product in a number of other countries under various trade names. This page is provided for general educational reference only.
FAQ
Click on a question to see more
-
What is thymosin alpha-1?
Thymosin alpha-1 (also written Tα1 or thymalfasin) is a 28-amino-acid peptide fragment that was first identified in extracts of the thymus gland. It is now made synthetically and has been studied in laboratory and clinical research settings. It is a frequently referenced compound in scientific literature on the immune system.
-
Is thymosin alpha-1 FDA-approved?
No. Thymosin alpha-1 is not approved by the U.S. Food and Drug Administration and is considered a research peptide in the United States. A synthetic form is registered as a pharmaceutical product in some other countries, but regulatory status differs by jurisdiction.
-
Does Cienega Medical offer thymosin alpha-1?
No. Thymosin alpha-1 is not offered at Cienega Medical. This page exists purely as general educational reference and is not an offer of any product or service.
Cared for by our 15-person Los Angeles medical team. Meet your provider →